Litcius/Paper detail

Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy

Claudia Schweizer, Philipp Schubert, Sandra Rutzner, Markus Eckstein, Marlen Haderlein, Sebastian Lettmaier, Sabine Semrau, Antoniu‐Oreste Gostian, Benjamin Frey, Udo S. Gaipl, Jian‐Guo Zhou, Rainer Fietkau, Markus Hecht

2020European Journal of Cancer37 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRadiation therapyAdverse effectProspective cohort studyInternal medicineOncologyImmunotherapyLung cancerMelanomaSurgeryCancerCancer researchCancer Immunotherapy and BiomarkersColorectal and Anal CarcinomasRadiomics and Machine Learning in Medical Imaging
Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy | Litcius